Autoimmune Liver Disease. Группа авторов

      1 1 Devarapu, S.K., Lorenz, G., Kulkarni, O.P. et al. (2017). Cellular and molecular mechanisms of autoimmunity and lupus nephritis. Int. Rev. Cell Mol. Biol 332: 43–154.

      2 2 Gambino, C.M., Aiello, A., Accardi, G. et al. (2018). Autoimmune diseases and 8.1 ancestral haplotype: an update. HLA 92 (3): 137–143.

      3 3 Toubi, E. and Vadasz, Z. (2019). Innate immune‐responses and their role in driving autoimmunity. Autoimmun. Rev 18 (3): 306–311.

      4 4 Caso, F., Costa, L., Nucera, V. et al. (2018). From autoinflammation to autoimmunity: old and recent findings. Clin. Rheumatol 37 (9): 2305–2321.

      5 5 Shen, H.H., Yang, Y.X., Meng, X. et al. (2018). NLRP3: a promising therapeutic target for autoimmune diseases. Autoimmun. Rev 17 (7): 694–702.

      6 6 Grant, C.R. and Liberal, R. (2017). Liver immunology: how to reconcile tolerance with autoimmunity. Clin. Res. Hepatol. Gastroenterol 41 (1): 6–16.

      7 7 Chiba, A., Murayama, G., and Miyake, S. (2018). Mucosal‐associated invariant T cells in autoimmune diseases. Front. Immunol. 9: 1333.

      8 8 Cheng, M. and Anderson, M.S. (2018). Thymic tolerance as a key brake on autoimmunity. Nat. Immunol 19 (7): 659–664.

      9 9 Ray, A. and Dittel, B.N. (2017). Mechanisms of regulatory B cell function in autoimmune and inflammatory diseases beyond IL‐10. J. Clin. Med 6 (1): 12.

      10 10 Theofilopoulos, A.N., Kono, D.H., and Baccala, R. (2017). The multiple pathways to autoimmunity. Nat. Immunol 18 (7): 716–724.

      11 11 Dominguez‐Villar, M. and Hafler, D.A. (2018). Regulatory T cells in autoimmune disease. Nat. Immunol 19 (7): 665–673.

      12 12 Taher, T.E., Bystrom, J., Ong, V.H. et al. (2017). Intracellular B lymphocyte signalling and the regulation of humoral immunity and autoimmunity. Clin. Rev. Allergy Immunol 53 (2): 237–264.

      13 13 Phillips, B.E., Garciafigueroa, Y., Engman, C. et al. (2019). Tolerogenic dendritic cells and T‐regulatory cells at the clinical trials crossroad for the treatment of autoimmune disease: emphasis on type 1 diabetes therapy. Front. Immunol. 10: 148.

      14 14 Lee, G.R. (2018). The balance of Th17 versus Treg cells in autoimmunity. Int. J. Mol. Sci 19 (3): 730.

      15 15 Inshaw, J.R.J., Cutler, A.J., Burren, O.S. et al. (2018). Approaches and advances in the genetic causes of autoimmune disease and their implications. Nat. Immunol 19 (7): 674–684.

      16 16 Tough, D.F. and Prinjha, R.K. (2017). Immune disease‐associated variants in gene enhancers point to BET epigenetic mechanisms for therapeutic intervention. Epigenomics 9 (4): 573–584.

      17 17 Di Marco, M., Ramassone, A., Pagotto, S. et al. (2018). MicroRNAs in autoimmunity and hematological malignancies. Int. J. Mol. Sci 19 (10): 3139.

      18 18 Moulton, V.R. (2018). Sex hormones in acquired immunity and autoimmune disease. Front. Immunol. 9: 2279.

      19 19 Dankers, W., Colin, E.M., van Hamburg, J.P., and Lubberts, E. (2016). Vitamin D in autoimmunity: molecular mechanisms and therapeutic potential. Front. Immunol. 7: 697.

      20 20 De Luca, F. and Shoenfeld, Y. (2019). The microbiome in autoimmune diseases. Clin. Exp. Immunol 195 (1): 74–85.

      21 21 Rojas, M., Restrepo‐Jimenez, P., Monsalve, D.M. et al. (2018). Molecular mimicry and autoimmunity. J. Autoimmun 95: 100–123.

      22 22 White, K.D., Chung, W.H., Hung, S.I. et al. (2015). Evolving models of the immunopathogenesis of T cell‐mediated drug allergy: the role of host, pathogens, and drug response. J. Allergy Clin. Immunol 136 (2): 219–234. quiz 235.

      23 23 Abdolmaleki, F., Farahani, N., Gheibi Hayat, S.M. et al. (2018). The role of efferocytosis in autoimmune diseases. Front. Immunol. 9: 1645.

      24 24 Wagner, D.H. Jr. (2017). Overlooked mechanisms in type 1 diabetes etiology: how unique costimulatory molecules contribute to diabetogenesis. Front. Endocrinol 8: 208.

      25 25 Molodtsov, A. and Turk, M.J. (2018). Tissue resident CD8 memory T cell responses in cancer and autoimmunity. Front. Immunol. 9: 2810.

      26 26 Chen, J., Caspi, R.R., and Chong, W.P. (2018). IL‐20 receptor cytokines in autoimmune diseases. J. Leukoc. Biol 104 (5): 953–959.

      27 27 Pipi, E., Nayar, S., Gardner, D.H. et al. (2018). Tertiary lymphoid structures: autoimmunity goes local. Front. Immunol. 9: 1952.

      28 28 Wang, M., Wu, L., Weng, R. et al. (2017). Therapeutic potential of helminths in autoimmune diseases: helminth‐derived immune‐regulators and immune balance. Parasitol. Res 116 (8): 2065–2074.

      29 29 Commins, S.P. (2015). Mechanisms of oral tolerance. Pediatr. Clin. North Am 62 (6): 1523–1529.